Neeupure Pharma Private Limited
About Neeupure Pharma Private Limited
Data last updated:
Neeupure Pharma Private Limited is a private limited company based in Hardwar, Uttarakhand, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 13 June 2023.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U21009UT2023PTC015794.
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1.2 Cr. It is led by directors Nikhil Goel and Mohan Singh Hari Singh Rawat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 222 Sector 7 Iie Sidcul, Hardwar, Uttarakhand, India – 249403.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.96 Cr. For the same year it recorded a net loss of ₹2.26 Lakh (net margin -1.2%) and EBITDA of ₹28.8 Lakh (EBITDA margin 14.7%).
As per MCA filings, the company has open charges of ₹4.98 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 222 Sector 7 Iie Sidcul, Hardwar, Uttarakhand, India – 249403
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Neeupure Pharma Private Limited
The main business activity of Neeupure Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Neeupure Pharma Private Limited FY 2025 filings available
Neeupure Pharma Private Limited reported revenue of ₹1.96 Cr for FY 2025.
Financial Statement Summary of Neeupure Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹28.8 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹2.26 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Neeupure Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 14.7% | •••• |
| Net Profit Margin | -1.2% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Neeupure Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Neeupure Pharma Private Limited
Neeupure Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Goel Also directs: Dr. Nise Private Limited | Director | 13 Jun 2023 | 3 Years 3 Months | Current |
| Mohan Singh Hari Singh Rawat | Director | 13 Jun 2023 | 3 Years 3 Months | Current |
Charges & Borrowings of Neeupure Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2023 | State Bank of India | ₹4.98 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Neeupure Pharma Private Limited
Employment history and EPFO contributions of people linked to Neeupure Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Neeupure Pharma Private Limited
Neeupure Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Mohan Singh Hari Singh Rawat was appointed as Director on 13 Jun 2023.
Credit Ratings, Litigation & Regulatory Alerts for Neeupure Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Neeupure Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Neeupure Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Neeupure Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Neeupure Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neeupure Pharma Private Limited
Neeupure Pharma is an active private limited company based in Hardwar, Uttarakhand, India. The company works in paper and paper products, within the paper industry. It was incorporated on 13 June 2023 (3+ years old) and is registered under CIN U21009UT2023PTC015794.
Neeupure Pharma reported revenue of ₹1.96 Cr for FY 2025.
Neeupure Pharma has 2 current directors:
- Nikhil Goel - Director
- Mohan Singh Hari Singh Rawat - Director
Neeupure Pharma reported a net loss of ₹2.26 Lakh (net margin -1.2%) and EBITDA of ₹28.8 Lakh (EBITDA margin 14.7%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Neeupure Pharma is U21009UT2023PTC015794. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neeupure Pharma was incorporated on 13 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Mohan Singh Hari Singh Rawat was appointed as Director on 13 Jun 2023. Nikhil Goel was appointed as Director on 13 Jun 2023.
The registered office of Neeupure Pharma is at Plot No. 222 Sector 7 Iie Sidcul, Hardwar, Uttarakhand, India – 249403.
Neeupure Pharma has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1.2 Cr.
Neeupure Pharma operates in the paper industry, in the paper and paper products segment.